Soligenix Inc.

NASDAQ:SNGX USA Biotechnology
Market Cap
$12.41 Million
Market Cap Rank
#27811 Global
#9303 in USA
Share Price
$1.23
Change (1 day)
+0.00%
52-Week Range
$1.04 - $4.96
All Time High
$3216.00
About

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the tre… Read more

Soligenix Inc. (SNGX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.386x

Based on the latest financial reports, Soligenix Inc. (SNGX) has a cash flow conversion efficiency ratio of -0.386x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.93 Million) by net assets ($7.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Soligenix Inc. - Cash Flow Conversion Efficiency Trend (1995–2024)

This chart illustrates how Soligenix Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Soligenix Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Soligenix Inc. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Soligenix Inc. (1995–2024)

The table below shows the annual cash flow conversion efficiency of Soligenix Inc. from 1995 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $4.12 Million $-8.40 Million -2.041x +40.17%
2023-12-31 $2.52 Million $-8.60 Million -3.411x -166.63%
2022-12-31 $-2.47 Million $-12.65 Million 5.119x +567.59%
2021-12-31 $10.72 Million $-11.74 Million -1.095x +64.23%
2020-12-31 $3.74 Million $-11.45 Million -3.061x +40.60%
2019-12-31 $1.46 Million $-7.51 Million -5.154x -346.76%
2018-12-31 $6.28 Million $-7.24 Million -1.154x -11.98%
2017-12-31 $6.32 Million $-6.51 Million -1.030x -52.95%
2016-12-31 $7.40 Million $-4.98 Million -0.674x -100.23%
2015-12-31 $-18.31K $-5.39 Million 294.189x +1735.32%
2014-12-31 $-153.89K $-2.47 Million 16.029x +536.51%
2013-12-31 $-1.77 Million $-4.46 Million 2.518x +439.32%
2012-12-31 $3.55 Million $-2.64 Million -0.742x -158.24%
2011-12-31 $6.79 Million $-1.95 Million -0.287x +63.10%
2010-12-31 $7.36 Million $-5.73 Million -0.779x -38.31%
2009-12-31 $8.17 Million $-4.60 Million -0.563x +60.07%
2008-12-31 $1.98 Million $-2.79 Million -1.410x +39.09%
2007-12-31 $2.59 Million $-6.00 Million -2.315x -161.97%
2006-12-31 $-1.11 Million $-4.14 Million 3.737x +222.25%
2005-12-31 $1.53 Million $-4.67 Million -3.057x -106.90%
2004-12-31 $2.98 Million $-4.41 Million -1.477x -83.67%
2003-12-31 $5.24 Million $-4.22 Million -0.804x +42.56%
2002-12-31 $4.29 Million $-6.00 Million -1.400x -192.57%
2001-12-31 $-2.63 Million $-3.98 Million 1.513x +562.42%
2000-12-31 $10.55 Million $-3.45 Million -0.327x -20.07%
1999-12-31 $7.26 Million $-1.98 Million -0.272x +2.32%
1998-12-31 $14.70 Million $-4.10 Million -0.279x -123.13%
1997-12-31 $18.40 Million $-2.30 Million -0.125x +90.67%
1996-12-31 $1.12 Million $-1.50 Million -1.339x -84.15%
1995-12-31 $1.38 Million $-1.00 Million -0.727x --